Given the parallels with pheochromocytoma-paraganglioma, it is possible that negative staining for SDHB may accompany SDHD -mutated renal-cell carcinoma.

Hereditary Paraganglioma-Pheochromocytoma Risks People born with hereditary paraganglioma-pheochromocytoma face an increased risk of developing tumors as they age.

The Paraganglioma Clinic helps patients and their families create personal screening plans. We also help schedule follow-up care for people at high risk for paragangliomas. Our health care team ...

Clinical manifestations of hereditary paraganglioma are determined by the sex of the transmitting parent.

A patient with kidney disease of unknown origin had mostly unremarkable findings. It was only when he mentioned having noticed white powder on his lunch that a diagnosis became clearer.

The two conditions — called Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) and Succinate Dehydrogenase-related Hereditary Paraganglioma and Pheochromocytoma (SDHPGL / PCC) — boost the risk of ...

Hereditary breast cancers are caused by germline mutations, which are genetic mutations inherited at conception and so called because they originate in germ cells, those that develop into ...

The increased incorporation of genetic and genomic testing in the pediatric oncology setting, including the use of larger and more comprehensive multigene panels and whole-exome sequencing, has ...

Researchers have identified the gene that is mutated in a hereditary form of a rare neuroendocrine tumor called paraganglioma. The gene, called hSDH5, is required for activation of an enzyme ...

The two conditions -- called Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) and Succinate Dehydrogenase-related Hereditary Paraganglioma and Pheochromocytoma (SDH PGL/PCC) -- boost the ...

The two conditions—called Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) and Succinate Dehydrogenase-related Hereditary Paraganglioma and Pheochromocytoma (SDH PGL/PCC)—boost the risk ...